Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|March 4, 2006
Unusual entry to the novel 8-halo-N1-ribosyl hypoxanthine system by degradation of a cyclic adenosine-5'-diphosphate ribose analogueChristelle Moreau, Timothy J Woodman, Barry V L PotterClinical & Experimental Optometry|June 16, 2017
Smoking and the eye: what Québec teenagers know and fearJulie Brûlé, Benoît Tousignant, Stéphanie Marcotte, et al.Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Chemical synthesis of the novel Ca2+ messenger NAADPJames Dowden, Richard S Brown, Christelle Moreau, et al.Journal of Medicinal Chemistry|August 18, 2006
Structural determinants for N1/N7 cyclization of nicotinamide hypoxanthine 5'-dinucleotide (NHD+) derivatives by ADP-ribosyl cyclase from aplysia californica: Ca2+-mobilizing activity of 8-substituted cyclic inosine 5'-diphosphoribose analogues in T-lymphocytesChristelle Moreau, Gerd K Wagner, Karin Weber, et al.Chemistry & Biology|June 24, 2006
Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ releaseJames Dowden, Georgina Berridge, Christelle Moreau, et al.Organic & Biomolecular Chemistry|October 27, 2010
Synthesis of cyclic adenosine 5'-diphosphate ribose analogues: a C2'endo/syn "southern" ribose conformation underlies activity at the sea urchin cADPR receptorChristelle Moreau, Gloria A Ashamu, Victoria C Bailey, et al.Journal of Medicinal Chemistry|January 18, 2012
Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cellsChristelle Moreau, Tanja Kirchberger, Bo Zhang, et al.The Journal of Biological Chemistry|June 27, 2007
Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analogQun Liu, Irina A Kriksunov, Christelle Moreau, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 7, 2023
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in ChildrenClaire Dossier, Stéphanie Bonneric, Véronique Baudouin, et al.BMC Cancer|December 5, 2022
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelaeAntoine Boden, Amélie Lusque, Sabrina Lodin, et al.Pageof 2